GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Veru Inc (FRA:FMW) » Definitions » Net Margin %

Veru (FRA:FMW) Net Margin % : -277.43% (As of Jun. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Veru Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Veru's Net Income for the three months ended in Jun. 2024 was €-10.19 Mil. Veru's Revenue for the three months ended in Jun. 2024 was €3.67 Mil. Therefore, Veru's net margin for the quarter that ended in Jun. 2024 was -277.43%.

The historical rank and industry rank for Veru's Net Margin % or its related term are showing as below:

FRA:FMW' s Net Margin % Range Over the Past 10 Years
Min: -571.6   Med: -41.17   Max: 13.33
Current: -265.42


FRA:FMW's Net Margin % is ranked worse than
57.32% of 1024 companies
in the Biotechnology industry
Industry Median: -143.61 vs FRA:FMW: -265.42

Veru Net Margin % Historical Data

The historical data trend for Veru's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Veru Net Margin % Chart

Veru Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -37.78 -44.55 12.07 -213.55 -571.60

Veru Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -374.81 -210.56 -386.60 -242.48 -277.43

Competitive Comparison of Veru's Net Margin %

For the Biotechnology subindustry, Veru's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Veru's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Veru's Net Margin % distribution charts can be found below:

* The bar in red indicates where Veru's Net Margin % falls into.



Veru Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Veru's Net Margin for the fiscal year that ended in Sep. 2023 is calculated as

Net Margin=Net Income (A: Sep. 2023 )/Revenue (A: Sep. 2023 )
=-87.284/15.27
=-571.60 %

Veru's Net Margin for the quarter that ended in Jun. 2024 is calculated as

Net Margin=Net Income (Q: Jun. 2024 )/Revenue (Q: Jun. 2024 )
=-10.19/3.673
=-277.43 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Veru  (FRA:FMW) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Veru Net Margin % Related Terms

Thank you for viewing the detailed overview of Veru's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Veru Business Description

Traded in Other Exchanges
Address
2916 North Miami Avenue, Suite 1000, Miami, FL, USA, 33127
Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology and acute respiratory distress syndrome (ARDS). The company is also in the late stage development of certain drugs for management of breast and prostate cancers. It also has a sexual health program which includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in single segment and generates revenue from USA which is the key revenue generating market, South Africa and other regions.

Veru Headlines

No Headlines